Posts by tag
overtreatment
If the risk is very low, should we still call it ‘cancer’?
'Cancer’ is the weightiest of words. Jacky remembers the impact those two short syllables had when she was given her results after tests for breast cancer. “I went into this little room and they told me that I had cancer…
Rise in initiation of immunotherapy at the end of life
Immunotherapy is increasingly being initiated in the month prior to death in patients with stage IV non-small-cell lung cancer, melanoma, and renal cell carcinoma. The US study, published in JAMA Oncology, online January 4, showed the practice was more common…
Stopping immunotherapy after two years does not affect NSCLC survival
No overall survival difference was found between patients with non-small cell lung cancer who stopped immune checkpoint inhibitors at two years and those continuing treatment indefinitely. The study, abstract 9101, presented at the ASCO 2023 Annual Meeting, held June 2–6,…
PSA population screening is back in favour: here’s why
Five years ago, the idea of national screening programmes for prostate cancer had gone cold. The benefits of PSA (prostate specific antigen) blood testing, introduced as a screening tool in the 1980s, had long been fiercely debated. But by 2015…